GlassScriptPhysician profile
Anupama Kottam
NPI 1861633414
$1,972.07
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $279 · 2021: $693 · 2022: $376 · 2023: $35.85 · 2024: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $216.19 | 2019-2022 | |
| Pfizer INC. | $189.85 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.73 | 2019-2022 | |
| Irhythm Technologies, INC. | $170.96 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $144.17 | 2021-2023 | Azure Xt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $133.52 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $104.46 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $83.31 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $81.99 | 2019-2021 | |
| Corcept Therapeutics | $81.97 | 2021 | |
| Becton, Dickinson and Company | $81.67 | 2019-2021 | |
| Amgen INC. | $60.70 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $57.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.46 | 2021-2022 | |
| Lilly USA, LLC | $41.48 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $32.58 | 2021 | |
| Medtronic Vascular, INC. | $30.73 | 2020 | |
| Sobi, INC | $26.73 | 2021 | |
| Lantheus Medical Imaging, INC. | $26.06 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $25.12 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $23.48 | 2019 | |
| Bracco Diagnostics INC. | $22.76 | 2019 | |
| Zealand Pharma US, INC. | $19.64 | 2021 | |
| Akcea Therapeutics, INC. | $18.73 | 2019 | |
| Amarin Pharma, INC. | $16.31 | 2021 | |
| Esperion Therapeutics, INC. | $16.16 | 2020 | |
| Radius Health, INC. | $13.90 | 2020 | |
| Electromed, INC. | $12.75 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anupama Kottam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.